Fertility preservation options may be needed for PARP inhibitor

Fertility preservation may need to be a future consideration for young women being treated with the PARP inhibitor olaparib according to Australian researchers who found it disrupts primordial follicle oocyte maintenance and survival in an animal model. Because direct measures of primordial follicle numbers is not possible in women, the findings have important implications for ...